07.01.2013
- Sanofi is pleased to announce today the appointment of Dr. Gary J. Nabel, M.D., Ph.D., to Chairman of the Strategic Development and Scientific Advisory Council (SDSAC). Dr. Nabel...
03.01.2013
- Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
19.12.2012
- The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...
18.12.2012
- European regulators recommended against approval of Sanofi and Isis Pharmaceutical's Kynamro drug for treatment of a rare genetic disorder that causes unusually high cholesterol...
14.12.2012
- Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could...
11.12.2012
- Denmark's Novo Nordisk is sizing up a high-price niche market for its drug liraglutide as a weight-loss treatment, with the United States the prime opportunity. The premium-price...
07.12.2012
- Bayer is unlikely to sell its blood glucose meters business for the time being, after failing to generate sufficient interest from buyers, two people familiar with the situation...
04.12.2012
- Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...